David Loesch
Impact in
- Oncology top 1%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 29
- Cancer Treatment and Pharmacology 20
- HER2/EGFR in Cancer Research 9
- Lung Cancer Research Studies 5
-
- Breast Cancer Treatment Studies 10
- Cancer Genomics and Diagnostics 5
- Co-authors
- Lina Asmar (12 shared papers)Joyce O’Shaughnessy (4 shared papers)J. Wanders (3 shared papers)Joanne L. Blum (3 shared papers)Véronique Dièras (1 shared paper)P. Chollet (1 shared paper)Fátima Cardoso (1 shared paper)Philippe Bougnoux (1 shared paper)
- Journals
- Journal of Clinical Oncology (20 papers)Breast Cancer Research and Treatment (2 papers)Cancer (1 paper)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
David Loesch
38 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.9k
- Cancer Research 834
- Pulmonary and Respiratory Medicine 983
- Clinical Biochemistry 94
- Infectious Diseases 191
Countries citing papers authored by David Loesch
This map shows the geographic impact of David Loesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Loesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Loesch more than expected).
Fields of papers citing papers by David Loesch
This network shows the impact of papers produced by David Loesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Loesch. The network helps show where David Loesch may publish in the future.
Co-authors
The 25 scholars most cited alongside David Loesch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Hit paper breakdown → | 2011 | 807 |
| 2 | 2010 | 434 | |
| 3 | 2006 | 342 | |
| 4 | 2008 | 304 | |
| 5 | An Outbreak of Infections Caused by Strains of Staphylococcus aureus Resistant to Methicillin and Aminoglycosides. | 1979 | 162 |
| 6 | 2011 | 128 | |
| 7 | 1999 | 109 | |
| 8 | 2014 | 57 | |
| 9 | 2002 | 47 | |
| 10 | 2011 | 44 | |
| 11 | 2004 | 35 | |
| 12 | 2004 | 28 | |
| 13 | 2008 | 24 | |
| 14 | 2015 | 24 | |
| 15 | 2008 | 21 | |
| 16 | 2010 | 17 | |
| 17 | 2008 | 14 | |
| 18 | 2010 | 12 | |
| 19 | 2004 | 12 | |
| 20 | 2011 | 11 |
About David Loesch
David Loesch is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 38 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), Breast Cancer Treatment Studies (10 papers), HER2/EGFR in Cancer Research (9 papers), Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Research Studies (5 papers), Cancer Genomics and Diagnostics (5 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (834 citations), Pulmonary and Respiratory Medicine (983 citations), Clinical Biochemistry (94 citations) and Infectious Diseases (191 citations). David Loesch has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lina Asmar, Joyce O’Shaughnessy, J. Wanders, Joanne L. Blum, Véronique Dièras, P. Chollet, Fátima Cardoso, Philippe Bougnoux, Corina E. Dutcus and Linda T. Vahdat. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer, Clinical Cancer Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.